New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase.
Sign Up to like & getrecommendations! Published in 2019 at "Antiviral research"
DOI: 10.1016/j.antiviral.2019.04.001
Abstract: Human parainfluenza viruses cause acute respiratory tract infections and disease predominantly in young children and immunocompromised individuals. Currently, there are no vaccines to prevent hPIV infections, nor licensed anti-hPIV drugs. There is therefore a need… read more here.
Keywords: human parainfluenza; new antiviral; haemagglutinin neuraminidase; antiviral approaches ... See more keywords